Key result
Continued anticoagulant therapy throughout the antenatal and puerperal period resulted in a successful twin pregnancy outcome in a patient with protein C deficiency and recurrent pregnancy losses.
Why the study?
Inherited thrombophilias in pregnancy carry increased risks of venous thromboembolism and adverse pregnancy outcomes, but the evidence for management and adequate thromboprophylaxis is not sharply defined.
Does continued anticoagulant therapy improve pregnancy outcomes in a pregnant female with protein C deficiency, prior VTE, and bad obstetric history?
Case Report (n=1)
Does continued anticoagulant therapy improve pregnancy outcomes in a pregnant female with protein C deficiency, prior VTE, and bad obstetric history?
Thromboprophylaxis throughout the antenatal course may improve pregnancy outcomes in patients with protein C deficiency and recurrent pregnancy losses.
No takes yet. Share an insight, caveat, or question.
Heightened VTE vigilance and adverse-outcome monitoring remain prudent in thrombophilia pregnancies; leaves open optimal screening and therapy protocols.
Anant et al. (2021) conducted a case report in Protein C deficiency, twin pregnancy, and bad obstetric history (n=1). Anticoagulant therapy (thromboprophylaxis) was evaluated on Pregnancy outcome. Continued anticoagulant therapy throughout the antenatal and puerperal period resulted in a successful twin pregnancy outcome in a patient with protein C deficiency and recurrent pregnancy losses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: